FDA budget
This article was originally published in The Rose Sheet
Executive Summary
President Bush's fiscal 2004 budget proposal calls for $1 mil. increase in funding for OTC-related activity, which would be used in part to "develop and work toward finalizing standards...for analgesic, antiseptic, laxative and sunscreen drug products for OTC use." Increase would boost OTC budget 10.6% to nearly $10.4 mil. and would be used to add seven full time equivalent OTC employees, bringing the total number to 69. Under the proposal, Center for Food Safety and Applied Nutrition spending would decrease 2.5% to $144.4 mil., but the decline would be offset by increased funding for field activities, which would grow 1.8% to $268.9 mil. FDA's total FY '04 budget request comes to almost $1.41 bil., up about 1.6% from the FY 2003 proposed funding level. Including user fees, the agency is requesting $1.71 bil., a 3.5% increase...
You may also be interested in...
Omnibus appropriations signed
President Bush signs H.J. Res. 2 on Feb. 20, providing federal government $397.4 bil. for FY 2003. House and Senate agreed to conference report Feb. 13. Budget provides $1 mil. in increased funding for OTC-related activity (1"The Rose Sheet" Feb. 10, 2003, In Brief)...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.